Chargement en cours...
PC945, a Novel Inhaled Antifungal Agent, for the Treatment of Respiratory Fungal Infections
Disease due to pulmonary Aspergillus infection remains a significant unmet need, particularly in immunocompromised patients, patients in critical care and those with underlying chronic lung diseases. To date, treatment using inhaled antifungal agents has been limited to repurposing available systemi...
Enregistré dans:
| Publié dans: | J Fungi (Basel) |
|---|---|
| Auteurs principaux: | , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
MDPI
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7765807/ https://ncbi.nlm.nih.gov/pubmed/33348852 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jof6040373 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|